Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01625260
Title A Study of ALT-801 in Patients With Bacillus Calmette-Guerin (BCG) Failure Non-Muscle Invasive Bladder Cancer
Recruitment Unknown status
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Altor Bioscience Corporation
Indications

bladder urothelial carcinoma

Therapies

ALT-801

ALT-801 + Gemcitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.